INDV Key Statistics, Chart & Performance
The current stock price of INDV is 36.19 USD. In the past month the price increased by 3.05%. In the past year, price increased by 205.4%.
INDV Latest News, Press Relases and Analysis
INDV Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 48.39 | 1.01T | ||
| JNJ | JOHNSON & JOHNSON | 19.73 | 493.40B | ||
| MRK | MERCK & CO. INC. | 12.36 | 270.22B | ||
| PFE | PFIZER INC | 7.95 | 144.59B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 8.3 | 110.79B | ||
| ZTS | ZOETIS INC | 20.4 | 57.00B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 9.89 | 23.46B | ||
| VTRS | VIATRIS INC | 5.32 | 14.28B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 24.79 | 11.83B | ||
| AXSM | AXSOME THERAPEUTICS INC | N/A | 8.66B | ||
| BLTE | BELITE BIO INC - ADR | N/A | 5.59B | ||
| CRNX | CRINETICS PHARMACEUTICALS IN | N/A | 4.36B |
Related stock screener links
About INDV
Company Profile
Indivior PLC is a holding company, which engages in the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence. The company is headquartered in Slough, Berkshire and currently employs 1,030 full-time employees. The company went IPO on 2014-12-24. The firm provides treatment for addiction, including SUBLOCADE (buprenorphine extended-release) injection for subcutaneous use, a long-acting injectable (LAI) for opioid use disorder and OPVEE (Nalmefene) nasal spray for opioid overdose recovery. Its core products include SUBOXONE Film, SUBOXONE Tablet, SUBUTEX Tablet, OPVEE (nalmefene), and SUBLOCADE. SUBOXONE Film is a buprenorphine and naloxone sublingual film. SUBOXONE Tablet is a buprenorphine and naloxone sublingual tablet. SUBUTEX Tablet is a buprenorphine sublingual tablet. SUBOXONE Film, SUBOXONE Tablet, SUBUTEX Tablet, and SUBLOCADE are treatments for opioid use disorder (OUD). In addition to its commercially available products, its product pipeline includes two drug candidates for the treatment of OUD. The firm sells its products in the United States and in other selected areas of the world.
Company Info
INDIVIOR PLC
234 Bath Road
SLOUGH BERKSHIRE GB
Employees: 1030
Phone: 448043791090
INDIVIOR PLC / INDV FAQ
What does INDV do?
Indivior PLC is a holding company, which engages in the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence. The company is headquartered in Slough, Berkshire and currently employs 1,030 full-time employees. The company went IPO on 2014-12-24. The firm provides treatment for addiction, including SUBLOCADE (buprenorphine extended-release) injection for subcutaneous use, a long-acting injectable (LAI) for opioid use disorder and OPVEE (Nalmefene) nasal spray for opioid overdose recovery. Its core products include SUBOXONE Film, SUBOXONE Tablet, SUBUTEX Tablet, OPVEE (nalmefene), and SUBLOCADE. SUBOXONE Film is a buprenorphine and naloxone sublingual film. SUBOXONE Tablet is a buprenorphine and naloxone sublingual tablet. SUBUTEX Tablet is a buprenorphine sublingual tablet. SUBOXONE Film, SUBOXONE Tablet, SUBUTEX Tablet, and SUBLOCADE are treatments for opioid use disorder (OUD). In addition to its commercially available products, its product pipeline includes two drug candidates for the treatment of OUD. The firm sells its products in the United States and in other selected areas of the world.
What is the stock price of INDIVIOR PLC today?
The current stock price of INDV is 36.19 USD. The price decreased by -0.17% in the last trading session.
Does INDV stock pay dividends?
INDV does not pay a dividend.
How is the ChartMill rating for INDIVIOR PLC?
INDV has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
Can you provide the market cap for INDIVIOR PLC?
INDIVIOR PLC (INDV) has a market capitalization of 4.52B USD. This makes INDV a Mid Cap stock.
Can you provide the upcoming earnings date for INDIVIOR PLC?
INDIVIOR PLC (INDV) will report earnings on 2026-02-18, after the market close.
Can you provide the ownership details for INDV stock?
You can find the ownership structure of INDIVIOR PLC (INDV) on the Ownership tab.
INDV Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to INDV. When comparing the yearly performance of all stocks, INDV is one of the better performing stocks in the market, outperforming 98.2% of all stocks.
INDV Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to INDV. INDV has an excellent profitability rating, but there are some minor concerns on its financial health.
INDV Financial Highlights
Over the last trailing twelve months INDV reported a non-GAAP Earnings per Share(EPS) of 1.96. The EPS increased by 256.36% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 10.34% | ||
| ROA | 8.62% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
INDV Forecast & Estimates
13 analysts have analysed INDV and the average price target is 38.61 USD. This implies a price increase of 6.7% is expected in the next year compared to the current price of 36.19.
For the next year, analysts expect an EPS growth of 438.48% and a revenue growth 2.65% for INDV